Kang Stem Biotech Co Ltd
KOSDAQ:217730
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kang Stem Biotech Co Ltd
KOSDAQ:217730
|
KR |
|
Oyang Corp
KRX:006090
|
KR |
|
T
|
TST Group Holding Ltd
TWSE:4439
|
TW |
|
C
|
CP Tower Leasehold Real Estate Investment Trust
SET:CPTREIT
|
TH |
|
Premco Global Ltd
BSE:530331
|
IN |
|
FFD Financial Corp
OTC:FFDF
|
US |
|
C
|
Cube Co Ltd (Minato)
TSE:7112
|
JP |
|
Consolidated Woodjam Copper Corp
XTSX:WCC
|
CA |
|
B
|
BH Co Ltd
KRX:090460
|
KR |
|
Sangoma Technologies Corp
TSX:STC
|
CA |
|
H
|
Hanjin Heavy Ind & Const Holdings Co Ltd
KRX:003480
|
KR |
|
Lucapa Diamond Co Ltd
ASX:LOM
|
AU |
|
Desh Rakshak Aushdhalaya Ltd
BSE:531521
|
IN |
|
Cartesian Growth Corp III
NASDAQ:FAC
|
US |
|
N
|
Now Corp
OTC:NWPN
|
US |
|
C
|
CCC SA
SWB:6RK
|
PL |
|
Tarku Resources Ltd
XTSX:TKU
|
CA |
Bankruptcy Probability
Kang Stem Biotech Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kang Stem Biotech Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
K
|
Kang Stem Biotech Co Ltd
KOSDAQ:217730
|
272.3B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
65.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kang Stem Biotech Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kang Stem Biotech Co Ltd has total debt of 8.3B KRW. This includes both short-term (4.8B KRW) and long-term (3.5B KRW) debt.
You can find a full breakdown on its Balance Sheet.
